Next Article in Journal
In Vitro Activity of Cefepime/AAI101 and Comparators against Cefepime Non-susceptible Enterobacteriaceae
Next Article in Special Issue
Systems Level Dissection of Candida Recognition by Dectins: A Matter of Fungal Morphology and Site of Infection
Previous Article in Journal
Assessing the Surrogate Susceptibility of Oxacillin and Cefoxitin for Commonly Utilized Parenteral Agents against Methicillin-Susceptible Staphylococcus aureus: Focus on Ceftriaxone Discordance between Predictive Susceptibility and in Vivo Exposures
Previous Article in Special Issue
Coordination of Candida albicans Invasion and Infection Functions by Phosphoglycerol Phosphatase Rhr2
Open AccessReview

Interleukin 17-Mediated Host Defense against Candida albicans

Section of Immunology, Institute of Virology, University of Zürich, Winterthurerstrasse 266a, Zürich, CH-8057, Switzerland
*
Author to whom correspondence should be addressed.
Academic Editor: Sarah Gaffen
Pathogens 2015, 4(3), 606-619; https://doi.org/10.3390/pathogens4030606
Received: 17 July 2015 / Revised: 6 August 2015 / Accepted: 7 August 2015 / Published: 12 August 2015
(This article belongs to the Special Issue Candida Albicans Infections)
Candida albicans is part of the normal microbiota in most healthy individuals. However, it can cause opportunistic infections if host defenses are breached, with symptoms ranging from superficial lesions to severe systemic disease. The study of rare congenital defects in patients with chronic mucocutaneous candidiasis led to the identification of interleukin-17 (IL-17) as a key factor in host defense against mucosal fungal infection. Experimental infections in mice confirmed the critical role of IL-17 in mucocutaneous immunity against C. albicans. Research on mouse models has also contributed importantly to our current understanding of the regulation of IL-17 production by different cellular sources and its effector functions in distinct tissues. In this review, we highlight recent findings on IL-17-mediated immunity against C. albicans in mouse and man. View Full-Text
Keywords: interleukin 17; chronic mucocutaneous candidiasis; mouse models interleukin 17; chronic mucocutaneous candidiasis; mouse models
MDPI and ACS Style

Sparber, F.; LeibundGut-Landmann, S. Interleukin 17-Mediated Host Defense against Candida albicans. Pathogens 2015, 4, 606-619. https://doi.org/10.3390/pathogens4030606

AMA Style

Sparber F, LeibundGut-Landmann S. Interleukin 17-Mediated Host Defense against Candida albicans. Pathogens. 2015; 4(3):606-619. https://doi.org/10.3390/pathogens4030606

Chicago/Turabian Style

Sparber, Florian; LeibundGut-Landmann, Salomé. 2015. "Interleukin 17-Mediated Host Defense against Candida albicans" Pathogens 4, no. 3: 606-619. https://doi.org/10.3390/pathogens4030606

Find Other Styles

Article Access Map by Country/Region

1
Only visits after 24 November 2015 are recorded.
Search more from Scilit
 
Search
Back to TopTop